We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GIL:TSXGildan Activewear Inc. Analysis

Data as of 2026-03-14 - not real-time

CA$80.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Gildan Activewear is trading at C$80.58, just above the calculated support of C$80.23 and well below its 52‑week high of C$100.44, suggesting limited upside risk in the near term. Technical indicators are mixed: the 20‑day SMA (C$91.77) and 50‑day SMA (C$91.18) sit above the current price, while the 200‑day SMA (C$79.96) is just below, and the RSI of 24 flags the stock as oversold. The MACD histogram remains negative (‑1.68) and the MACD signal is bearish, but volume is increasing, indicating renewed buying interest. On the fundamentals side, GIL posted a robust 31% year‑over‑year revenue growth to C$3.62 bn, with a gross margin of 32.2% and operating margin of 20.7%, underscoring strong pricing power. However, free cash flow is negative (‑C$1.02 bn) and the company carries a high debt‑to‑equity ratio of 132%, raising concerns about cash generation and dividend sustainability. The consensus analyst outlook is bullish, with a median 12‑month target of C$104.12, implying roughly 30% upside, yet the DCF‑derived fair value (C$61.94) suggests the market may be overpricing the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above technical support
  • RSI indicating oversold conditions
  • Bearish MACD despite rising volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong 31% revenue growth and expanding margins
  • Attractive forward PE of ~11 versus trailing PE of 23
  • Analyst consensus target implying ~30% upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High debt‑to‑equity ratio could limit financial flexibility
  • Dividend payout ratio modest but free cash flow negative
  • Consumer‑cyclical exposure may increase volatility over multiple years

Key Metrics & Analysis

Financial Health

Revenue Growth31.30%
Profit Margin11.02%
P/E Ratio23.0
ROE15.70%
ROA6.86%
Debt/Equity132.12
P/B Ratio3.1
Op. Cash FlowCA$606.3M
Free Cash FlowCA$-1016323136

Technical Analysis

TrendBullish
RSI24.0
SupportCA$80.23
ResistanceCA$100.44
MA 20CA$91.77
MA 50CA$91.18
MA 200CA$79.96
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCA$61.94
Target PriceCA$106.02
Upside/Downside31.57%
GradeOvervalued
TypeGrowth
Dividend Yield1.69%

Risk Assessment

Beta0.95
Volatility32.39%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.